Gotowe bibliografie tematyczne / Boron-neutron capture therapy

Spis treści

  1. Artykuły w czasopismach
  2. Rozprawy doktorskie
  3. Książki
  4. Części książek
  5. Streszczenia konferencji
  6. Raporty organizacyjne

Gotowa bibliografia na temat „Boron-neutron capture therapy”

Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 28 lipca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Boron-neutron capture therapy”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Boron-neutron capture therapy"

1

Taskaev, S. Yu. "Boron Neutron Capture Therapy". Physics of Atomic Nuclei 84, nr 2 (marzec 2021): 207–11. http://dx.doi.org/10.1134/s106377882101021x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

ONO, Koji, Minoru SUZUKI, Shinichiro MASUNAGA, Natsuko KONDO, Yoshinori SAKURAI, Hiroki TANAKA, Yuko KINASHI i Akira MARUHASHI. "Boron Neutron Capture Therapy". RADIOISOTOPES 61, nr 4 (2012): 209–22. http://dx.doi.org/10.3769/radioisotopes.61.209.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

FREEMANTLE, MICHAEL. "BORON NEUTRON CAPTURE THERAPY". Chemical & Engineering News 80, nr 34 (26.08.2002): 13. http://dx.doi.org/10.1021/cen-v080n034.p013.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Beddoe, A. H. "Boron neutron capture therapy." British Journal of Radiology 70, nr 835 (lipiec 1997): 665–67. http://dx.doi.org/10.1259/bjr.70.835.9245876.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Slatkin, Daniel N. "Boron neutron-capture therapy". Neutron News 1, nr 4 (styczeń 1990): 25–28. http://dx.doi.org/10.1080/10448639008229357.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Ota, Ichiro, i Tadashi Kitahara. "Boron Neutron Capture Therapy (BNCT)". Practica Oto-Rhino-Laryngologica 107, nr 12 (2014): 937–46. http://dx.doi.org/10.5631/jibirin.107.937.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

&NA;. "Improving boron neutron capture therapy". Inpharma Weekly &NA;, nr 971 (styczeń 1995): 8. http://dx.doi.org/10.2165/00128413-199509710-00016.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Mumot, M. "325. Boron Neutron Capture Therapy". Reports of Practical Oncology & Radiotherapy 8 (2003): S354—S355. http://dx.doi.org/10.1016/s1507-1367(03)70808-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Kato, I. "S17.1 Boron neutron capture therapy". Oral Oncology Supplement 1, nr 1 (styczeń 2005): 63. http://dx.doi.org/10.1016/s1744-7895(05)80118-x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Monti, V., M. Costa, E. Durisi, E. Mafucci, A. Calamida, A. I. Castro Campoy, A. Fontanilla, L. Russo i R. Bedogni. "Neutron spectroscopy for Boron Neutron Capture Therapy beams characterization". Journal of Instrumentation 19, nr 05 (1.05.2024): C05036. http://dx.doi.org/10.1088/1748-0221/19/05/c05036.

Pełny tekst źródła
Streszczenie:
Abstract Boron Neutron Capture Therapy (BNCT) is a therapeutic treatment for malignant tumors that utilizes the nuclear reactions that happen when thermal neutrons are captured by boron-10 atoms to selectively destroy designated cells. Boron-10 atoms are biochemically accumulated inside the tumor target, which is then irradiated with thermal neutrons. In recent years, the possibility to obtain accelerator based intense neutron beams has given a boost to the diffusion of BNCT also in Europe, removing the need of nuclear reactors. In this contest, the monitoring and characterization of the epithermal neutron beams dedicated to BNCT becomes an important issue. The directional neutron spectrometer called NCT-WES (Neutron Capture Therapy Wide Energy Spectrometer) is a single moderator neutron spectrometer composed of a polyethylene cylinder embedding six semiconductor-based detectors positioned at different depths along the cylinder axes. The position of the six detectors is studied in order to maximize the response of each one in a selected neutron energy range. The unfolding of the six simultaneous readings allows to reconstruct the incoming neutron energy spectrum as in a parallelized Bonner Sphere System. A cylindrical collimator situated in the front of the spectrometer makes the instrument sensitive to neutrons coming only from a given direction, which allows to exclude the contribution of the room scattered radiation. The experimental validation of the spectrometer, obtained through several measuring campaigns, is reported and discussed.
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Boron-neutron capture therapy"

1

Howard, William Bruce. "Accelerator-based boron neutron capture therapy". Thesis, Massachusetts Institute of Technology, 1997. http://hdl.handle.net/1721.1/44479.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Hefne, Jameel. "Neutron spectrum measurement for Boron Neutron Capture Therapy". Diss., Georgia Institute of Technology, 1996. http://hdl.handle.net/1853/16625.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Goorley, John Timothy 1974. "Boron neutron capture therapy treatment planning improvements". Thesis, Massachusetts Institute of Technology, 1998. http://hdl.handle.net/1721.1/49670.

Pełny tekst źródła
Streszczenie:
Thesis (S.M.)--Massachusetts Institute of Technology, Dept. of Nuclear Engineering, 1998.
Includes bibliographical references.
The Boron Neutron Capture Therapy (BNCT) treatment planning process of the Harvard/MIT team used for their clinical Phase I trials is very time consuming. If BNCT proves to be a successful treatment, this process must be made more efficient. Since the Monte Carlo treatment planning calculations were the most time consuming aspect of the treatment planning process, requiring more than thirty six hours for scoping calculations of three to five beams and final calculations for two beams, it was targeted for improvement. Three approaches were used to reduce the calculation times. A statistical uncertainty analysis was performed on doses rates and showed that a fewer number of particles could not be used and still meet uncertainty requirements in the region of interest. Unused features were removed and assumptions specific to the Harvard/MIT BNCT treatment planning calculations were hard wired into MCNP by Los Alamos personnel, resulting in a thirty percent decrease in runtimes. MCNP was also installed in parallel on the treatment planning computers, allowing a factor of improvement by roughly the number of computers linked together in parallel. After theses enhancements were made, the final executable, MCNPBNCT, was tested by comparing its calculated dose rates against the previously used executable, MCNPNEHD. Since the dose rates in close agreement, MCNPBNCT was adopted. The final runtime improvement to a single beam scoping run by linking the two 200MHz Pentium Pro computers was to reduce the wall clock runtime from 2 hours thirty minutes to fifty nine minutes. It is anticipated that the addition of ten 900 MHz CPUs will further reduce this calculation to three minutes, giving the medical physicist or radiation oncologist the freedom to use an iterative approach to try different radiation beam orientations to optimize treatment. Additional aspects of the treatment planning process were improved. The previously unrecognized phenomenon of peak dose movement during irradiation and its potential for overdosing the subject was identified. A method of predicting its occurrence was developed to prevent this from occurring. The calculated dose rate was also used to create dose volume histograms and volume averaged doses. These data suggest an alternative method for categorizing the subjects, rather than by peak tissue dose.
by John Timothy Goorley.
S.M.
Style APA, Harvard, Vancouver, ISO itp.
4

Matalka, Khalid Zuhair. "Boron neutron capture therapy of brain tumors /". The Ohio State University, 1992. http://rave.ohiolink.edu/etdc/view?acc_num=osu148778039326795.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Guidi, Claretta. "Sviluppo e applicazioni della boron neutron capture therapy". Bachelor's thesis, Alma Mater Studiorum - Università di Bologna, 2017. http://amslaurea.unibo.it/13399/.

Pełny tekst źródła
Streszczenie:
La Boron Neutron Capture Therapy è una tecnica terapeutica altamente selettiva, utilizzata in oncologia, che si basa sulla reazione di cattura neutronica 10B(n,α)7Li . Tale selettività è garantita dal maggior assorbimento di boro, tramite specifici veicolanti, da parte delle cellule tumorali rispetto alle cellule sane, che si mantengono inalterate. I prodotti della reazione di cattura sono particelle ad alto LET, quindi poco penetranti, e questo consente un rilascio energetico letale per i tessuti malati. L'obiettivo di questa tesi è fornire un quadro generale sulla Boron Neutron Capture Therapy, sottolineandone gli aspetti positivi e negativi. In particolare si illustrano, dopo un breve excursus storico, le principali caratteristiche fisiche e chimiche della terapia, quali la reazione di cattura neutronica da parte del boro, gli agenti di trasporto del boro e le sorgenti di neutroni. Si forniscono le principali informazioni riguardo al problema dosimetrico legato alla terapia e si analizzano le principali applicazioni cliniche in Italia e nel mondo, con particolare attenzione sul progetto TAOrMINA. Dal lavoro svolto si può concludere che la BNCT risulta efficace per la cura di molti tumori resistenti alle tradizionali terapie e fornisce una prospettiva positiva alla lotta contro le neoplasie. Tuttavia il raggiungimento della totale efficienza di questa tecnica appare ancora lontano a causa, principalmente, della mancanza di adeguate attrezzature nei centri ospedalieri e della necessità di migliorare ulteriormente la selettività e l'efficacia dei composti veicolanti del boro.
Style APA, Harvard, Vancouver, ISO itp.
6

Shah, Jungal (Jugal Kaushik). "Hypoxia-selective compounds for boron neutron capture therapy". Thesis, Massachusetts Institute of Technology, 2008. http://hdl.handle.net/1721.1/44829.

Pełny tekst źródła
Streszczenie:
Thesis (S.B.)--Massachusetts Institute of Technology, Dept. of Nuclear Science and Engineering, 2008.
"June 2008."
Includes bibliographical references.
Boron neutron capture therapy (BNCT) is a biochemically targeted form of radiotherapy for cancer. In BNCT, a compound labeled with the stable isotope boron-10 is systemically administered, and tumor cells selectively uptake the boron-10 containing compound at higher concentrations than normal cells. A general problem with the tumor seeking compounds is that drug delivery is dependent upon sufficient vascularization within the tumor. To investigate the possibility of delivering boron to hypoxic regions of tumor, a new boronated nitroimidazole delivery agent has been synthesized as a carrier of boron-10 for BNCT. It is expected that this will be used in combination with the existing boron carrier boronophenylalanine-fructose to treat solid tumors. An immunohistochemical protocol to visualize hypoxia was tested and refined to confirm the suitability of two tumor models established in the lab for hypoxia related uptake studies. The immunohistochemical protocol is used to detect pimonidazole, which localizes at hypoxic regions in tissue and is the parent compound for the new hypoxia-selective boron carrier. The protocol was used to test and confirm the suitability of a hypoxic in vivo tumor model. Two tumor lines were tested: SCCVII squamous cell carcinoma and EMT-6 murine mammary carcinoma. Both exhibited hypoxia. Finally, quantitative studies using Inductive Coupled Plasma Atomic Emission Spectrum demonstrated that the synthesized boronated nitroimidazole reaches suitable concentrations in SCCVII and F98 tumor. Future therapeutic studies are required to empirically confirm the effectiveness of this compound.
by Jugal Shah.
S.B.
Style APA, Harvard, Vancouver, ISO itp.
7

Wang, Zhonglu. "Design of a Boron Neutron Capture Enhanced Fast Neutron Therapy Assembly". Diss., Georgia Institute of Technology, 2006. http://hdl.handle.net/1853/14100.

Pełny tekst źródła
Streszczenie:
A boron neutron capture enhanced fast neutron therapy assembly has been designed for the Fermilab Neutron Therapy Facility (NTF). This assembly uses a tungsten filter and collimator near the patient¡¯s head, with a graphite reflector surrounding the head to significantly increase the dose due to boron neutron capture reactions. The assembly was designed using Monte Carlo radiation transport code MCNP version 5 for a standard 20x20 cm2 treatment beam. The calculated boron dose enhancement at 5.7-cm depth in a water-filled head phantom in the assembly with a 5x5 cm2 collimation was 21.9% per 100-ppm B-10 for a 5.0-cm tungsten filter and 29.8% for an 8.5-cm tungsten filter. The corresponding dose rate for the 5.0-cm and 8.5-cm thick filters were 0.221 and 0.127 Gy/min, respectively. To validate the design calculations, a simplified BNCEFNT assembly was built using four lead bricks to form a 5x5 cm2 collimator. Five 1.0-cm thick 20x20 cm2 tungsten plates were used to obtain different filter thicknesses and graphite bricks/blocks were used to form a reflector. Measurements of the dose enhancement of the simplified assembly in a water-filled head phantom were performed using a pair of tissue-equivalent ion chambers. One of the ion chambers is loaded with 1000-ppm natural boron (184-ppm 10B) to measure dose due to boron neutron capture. The measured dose enhancement at 5.0-cm depth in the head phantom for the 5.0-cm thick tungsten filter is (16.6 ¡À 1.8)%, which agrees well with the MCNP simulation of the simplified BNCEFNT assembly, (16.4¡À 0.5)%. The error in the calculated dose enhancement only considers the statistical uncertainties. The total dose rate measured at 5.0-cm depth using the non-borated ion chamber is (0.765 ¡À 0.076) Gy/MU, about 61% of the fast neutron standard dose rate (1.255Gy/MU) at 5.0-cm depth for the standard 10x10 cm2 treatment beam. The increased doses to other organs due to the use of the BNCEFNT assembly were calculated using MCNP5 and a MIRD phantom.
Style APA, Harvard, Vancouver, ISO itp.
8

Sweezy, Jeremy Ed. "Development of a boron neutron capture enhanced fast neutron therapy beam". Diss., Georgia Institute of Technology, 2002. http://hdl.handle.net/1853/17107.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Kudchadker, Rajat. "Optimized accelerator based epithermal neutron beams for boron neutron capture therapy /". free to MU campus, to others for purchase, 1996. http://wwwlib.umi.com/cr/mo/fullcit?p9821332.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Chung, Yoonsun. "Radiobiological evaluation of new boron delivery agents for boron neutron capture therapy". Thesis, Massachusetts Institute of Technology, 2008. http://hdl.handle.net/1721.1/44784.

Pełny tekst źródła
Streszczenie:
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Nuclear Science and Engineering, 2008.
Includes bibliographical references (p. 123-132).
This thesis evaluates the radiobiological effectiveness of three new boron compounds namely a boronated porphyrin (BOPP) and two liposome formulations for neutron capture therapy (BNCT). The methodology utilizes in vitro and in vivo comparisons that characterize compounds relative to boric acid and boronophenylalanine (BPA). In vitro evaluations utilized a colorimetric assay and 96-well plates to minimize the quantities of compound required for testing. The assay was optimized for the murine SCCVII, squamous cell carcinoma to determine the chemical toxicity and relative cellular uptake of a compound. BOPP was toxic at low concentrations and comparisons between the different compounds for thermal neutron irradiations were performed with approximately 5 [mu]g 10B/ml in the culture medium to allow radiation induced effects to govern the observed response. Using less than 300 [mu]g of compound and 250 kVp X-rays as control irradiations, a compound biological effectiveness (CBE) of 3.3 ± 0.7 was determined for BOPP that is comparable to the result for boric acid (3.5 ± 0.5) indicating a non-selective intracellular accumulation of 10B. BPA has a significantly higher CBE of 6.1 + 0.7. Boronated liposomes (MAC-16 and MAC+TAC) were evaluated with the EMT-6 murine mammary carcinoma. Biodistribution studies showed high 10B uptake in tumor (20-40 [mu]g 10B/g) 30 hours after a single i.v. injection (dose 6-20 [mu]g 10B per gram of body weight). Tumor control experiments were performed using thermal neutrons to study the efficacy of the boron delivered by liposomes and BPA. The MAC-16 produced a 16 % tumor control and BPA (dose 43 [mu]g 10B/gbw) 63 % for tumor boron concentrations of approximately 20 [mu]g 10B/g and the same neutron fluence.
(cont.) Liposome doses were limited by injection volume and so two injections were tried 2-hours apart that doubled the boron concentration in tumor compared to a single administration. This improved the therapeutic response to 67 % with less apparent skin damage than with BPA. Microscopic studies using fluorescent labeled liposomes revealed 10B was nonuniformly distributed and concentrated at the edge of the tumor. Based on these studies in the tumor cell lines chosen neither of the compounds appear superior to BPA.
by Yoonsun Chung.
Ph.D.
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Boron-neutron capture therapy"

1

Gabel, Detlef, i Ray Moss, red. Boron Neutron Capture Therapy. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3408-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

1932-, Hatanaka Hiroshi, red. Boron-neutron capture therapy for tumors. Niigata, Japan: Nishimura, 1986.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

1929-, Mishima Yutaka, i International Symposium on Neutron Capture Therapy (6th : 1994 : Kōbe-shi, Japan), red. Cancer neutron capture therapy. New York: Plenum Press, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Nievaart, Victor Alexander. Spectral tailoring for boron neutron capture therapy. Amsterdam: IOS Press, 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

H, Soloway Albert, Barth Rolf F, Carpenter David E. 1943-, International Society for Neutron Capture Therapy., International Union against Cancer, Arthur G. James Cancer Hospital and Research Institute. i International Symposium on Neutron Capture Therapy (5th : 1992 : Columbus, Ohio), red. Advances in neutron capture therapy. New York: Plenum Press, 1993.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Ross, David Ian. Various studies relating to boron neutron capture therapy. Birmingham: University of Birmingham, 1992.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Börje, Larsson, Crawford John i Weinreich Regin, red. Advances in neutron capture therapy: Proceedings of the Seventh International Symposium on Neutron Capture Therapy for Cancer, Zürich, Switzerland, 4-7 September 1996. Amsterdam: Elsevier, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Hosmane, Narayan S. Boron and gadolinium neutron capture therapy for cancer treatment. Singapore: World Scientific, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

G, Fairchild Ralph, Bond Victor P i Woodhead Avril D, red. Clinical aspects of neutron capture therapy. New York: Plenum Press, 1989.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

National Cancer Institute (U.S.). Division of Cancer Treatment. Radiation Research Program i Boron Workshop (1988 : Annapolis, Md.), red. Boron compounds suitable for neutron capture therapy for the treatment of cancer. [Bethesda, MD: The Program, 1988.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Boron-neutron capture therapy"

1

Yanch, Jacquelyn C. "Boron Neutron Capture Synovectomy". W Neutron Capture Therapy, 521–30. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-31334-9_31.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Nakagawa, Yoshinobu. "Boron Neutron Capture Therapy". W Frontiers in Neutron Capture Therapy, 73–79. Boston, MA: Springer US, 2001. http://dx.doi.org/10.1007/978-1-4615-1285-1_6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Perks, Christopher A., i Howard J. Delafield. "Neutron Spectrometry Measurements of the Petten HFR, HB11 Neutron Beam". W Boron Neutron Capture Therapy, 79–91. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3408-2_10.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Mauri, Pier Luigi, i Fabrizio Basilico. "Proteomic Investigations for Boron Neutron Capture Therapy". W Neutron Capture Therapy, 189–200. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-31334-9_10.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Kawabata, Shinji, i Shin-Ichi Miyatake. "Boron Neutron Capture Therapy for Malignant Meningiomas". W Neutron Capture Therapy, 399–406. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-31334-9_22.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Hondros, E. D. "Opening Speech". W Boron Neutron Capture Therapy, 1–3. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3408-2_1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Raaijmakers, Cornelis P. J., Luc Dewit, Mark W. Konijnenberg, Ben J. Mijnheer, Raymond L. Moss i Finn Stecher-Rasmussen. "A Semi-Empirical Method of Treatment Planning for Boron Neutron Capture Therapy". W Boron Neutron Capture Therapy, 93–100. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3408-2_11.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Watkins, Peter. "Present Status of the Three-Dimensional Treatment Planning Methodologies for the Petten BNCT Facility". W Boron Neutron Capture Therapy, 101–9. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3408-2_12.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Coderre, Jeffrey A. "A Phase 1 Biodistribution Study of p-Boronophenylalanine". W Boron Neutron Capture Therapy, 111–21. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3408-2_13.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Gahbauer, Reinhard A., Ralph G. Fairchild, Joseph H. Goodman i Thomas E. Blue. "RBE in Normal Tissue Studies". W Boron Neutron Capture Therapy, 123–28. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3408-2_14.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Boron-neutron capture therapy"

1

Stecher‐Rasmussen, F., R. L. Moss i M. W. Konijnenberg. "Boron Neutron Capture Therapy". W Capture gamma‐ray spectroscopy. American Institute of Physics, 1991. http://dx.doi.org/10.1063/1.41154.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Haque, A. M., G. Moschini, Vlado Valkovic i D. Zafiropoulos. "Boron-neutron capture therapy". W 4th International Conference on Applications of Nuclear Techniques: Neutrons and their Applications, redaktorzy George Vourvopoulos i Themis Paradellis. SPIE, 1995. http://dx.doi.org/10.1117/12.204194.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Gabel, Detlef. "Boron neutron capture therapy: from physics to treatment". W Fifth International Conference on Applications of Nuclear Techniques: Neutrons in Research and Industry, redaktor George Vourvopoulos. SPIE, 1997. http://dx.doi.org/10.1117/12.267842.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Kanda, Keiji. "Experience of boron neutron capture therapy in Japan". W Fifth International Conference on Applications of Nuclear Techniques: Neutrons in Research and Industry, redaktor George Vourvopoulos. SPIE, 1997. http://dx.doi.org/10.1117/12.267900.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Taskaev, Sergey. "Neutron source VITA for Boron Neutron Capture Therapy and other applications". W RAD Conference. RAD Centre, 2021. http://dx.doi.org/10.21175/rad.abstr.book.2021.16.2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Herrera, María S., Sara J. González, Daniel M. Minsky, Andrés J. Kreiner, Ricardo Alarcon, Phil Cole, Andres J. Kreiner i Hugo F. Arellano. "Treatment Planning for Accelerator-Based Boron Neutron Capture Therapy". W VIII LATIN AMERICAN SYMPOSIUM ON NUCLEAR PHYSICS AND APPLICATIONS. AIP, 2010. http://dx.doi.org/10.1063/1.3480233.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Shefer, Ruth E., Robert E. Klinkowstein i Jacquelyn C. Yanch. "High-current electrostatic accelerator for boron neutron capture therapy". W Fifth International Conference on Applications of Nuclear Techniques: Neutrons in Research and Industry, redaktor George Vourvopoulos. SPIE, 1997. http://dx.doi.org/10.1117/12.267922.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Yanch, J. C., R. E. Shefer, R. E. Klinkowstein, W. B. Howard, H. Song, B. Blackburn i E. Binello. "Research in Boron Neutron Capture Therapy at MIT LABA". W The fourteenth international conference on the application of accelerators in research and industry. AIP, 1997. http://dx.doi.org/10.1063/1.52637.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Singh, Bikramjeet, Paviter Singh, Manjeet Kumar, Anup Thakur i Akshay Kumar. "Single step synthesis of nanostructured boron nitride for boron neutron capture therapy". W PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON CONDENSED MATTER PHYSICS 2014 (ICCMP 2014). AIP Publishing LLC, 2015. http://dx.doi.org/10.1063/1.4915415.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Kanygin, V. V., A. I. Kichigin, A. L. Krivoshapkin i S. Yu Taskaev. "Perspectives of boron-neutron capture therapy of malignant brain tumors". W PHYSICS OF CANCER: INTERDISCIPLINARY PROBLEMS AND CLINICAL APPLICATIONS: Proceedings of the International Conference on Physics of Cancer: Interdisciplinary Problems and Clinical Applications (PC IPCA’17). Author(s), 2017. http://dx.doi.org/10.1063/1.5001609.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Boron-neutron capture therapy"

1

Maughan, R. L., i C. Kota. Microdosimetry for Boron Neutron Capture Therapy. Office of Scientific and Technical Information (OSTI), wrzesień 2000. http://dx.doi.org/10.2172/770637.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

N. Commercial Clinical Application of Boron Neutron Capture Therapy. Office of Scientific and Technical Information (OSTI), wrzesień 1999. http://dx.doi.org/10.2172/942161.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Dolan, T., E. Ottewitte, E. Wills, W. Neuman i D. Woodall. Non-reactor neutron sources for BNCT (Boron Neutron Capture Therapy). Office of Scientific and Technical Information (OSTI), maj 1989. http://dx.doi.org/10.2172/5876401.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Wang, Zhonglu. Design of a boron neutron capture enhanced fast neutron therapy assembly. Office of Scientific and Technical Information (OSTI), grudzień 2006. http://dx.doi.org/10.2172/892403.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Sweezy, Jeremy Ed. Development of a Boron Neutron Capture Enhanced Fast Neutron Therapy Beam. Office of Scientific and Technical Information (OSTI), styczeń 2002. http://dx.doi.org/10.2172/1420958.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

J. Vujic, E. Greenspan, W.E. Kastenber, Y. Karni, D. Regev, K. N. Leung J.M. Verbeke, D. Chivers i in. Optimal Neutron Source & Beam Shaping Assembly for Boron Neutron Capture Therapy. Office of Scientific and Technical Information (OSTI), kwiecień 2003. http://dx.doi.org/10.2172/810841.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Barnum, Beverly A., Yan Hao, Roger Moore, M. Frederick Hawthorne i Kurt Baum. Carborane derivative development for boron neutron capture therapy. Final report. Office of Scientific and Technical Information (OSTI), kwiecień 1999. http://dx.doi.org/10.2172/762720.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Dorn, R. V. III. Power Burst Facility/Boron Neutron Capture Therapy Program for cancer treatment. Redaktor A. L. Ackermann. Office of Scientific and Technical Information (OSTI), sierpień 1990. http://dx.doi.org/10.2172/6321857.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Ackermann, A. L., red. Power Burst Facility/Boron Neutron Capture Therapy Program for cancer treatment. Office of Scientific and Technical Information (OSTI), październik 1990. http://dx.doi.org/10.2172/6141929.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Dorn, R. V. III. Power Burst Facility/Boron Neutron Capture Therapy Program for cancer treatment. Redaktor A. L. Ackermann. Office of Scientific and Technical Information (OSTI), wrzesień 1990. http://dx.doi.org/10.2172/6168994.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Boron-neutron capture therapy” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii